Centene Co. (NYSE:CNC) Director Theodore R. Samuels II Acquires 5,000 Shares

Centene Co. (NYSE:CNC) Director Theodore R. Samuels II bought 5,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The shares were bought at an average cost of $58.86 per share, with a total value of $294,300.00. Following the completion of the purchase, the director now directly owns 23,000 shares of the company’s stock, valued at $1,353,780. This represents a 27.78 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website.

Centene Trading Down 2.3 %

Centene stock traded down $1.37 during mid-day trading on Tuesday, hitting $57.81. The company’s stock had a trading volume of 7,270,655 shares, compared to its average volume of 4,120,537. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The stock has a market cap of $29.18 billion, a PE ratio of 10.04, a P/E/G ratio of 0.78 and a beta of 0.46. The company has a 50 day moving average of $61.51 and a 200-day moving average of $68.41. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CNC. Park Place Capital Corp raised its position in Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after purchasing an additional 357 shares in the last quarter. WR Wealth Planners LLC lifted its stake in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares during the period. Chris Bulman Inc bought a new position in Centene during the 2nd quarter worth about $33,000. Crewe Advisors LLC increased its position in Centene by 174.3% during the 2nd quarter. Crewe Advisors LLC now owns 683 shares of the company’s stock valued at $45,000 after purchasing an additional 434 shares during the period. Finally, Private Trust Co. NA raised its holdings in shares of Centene by 75.3% in the 3rd quarter. Private Trust Co. NA now owns 773 shares of the company’s stock valued at $58,000 after purchasing an additional 332 shares in the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. UBS Group raised Centene from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $79.00 to $80.00 in a report on Friday. StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Wells Fargo & Company reduced their target price on shares of Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $90.00 price target on shares of Centene in a report on Wednesday, December 11th. Finally, Stephens reduced their price objective on Centene from $75.00 to $73.00 and set an “equal weight” rating on the stock in a research note on Friday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $80.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.